T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$4.95B |
| 2 |
Broadcom
AVGO
|
+$3.48B |
| 3 |
Microsoft
MSFT
|
+$2.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.92B |
| 5 |
GE Aerospace
GE
|
+$1.49B |
Top Sells
| 1 |
Amazon
AMZN
|
+$3.79B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.63B |
| 3 |
Apple
AAPL
|
+$2.46B |
| 4 |
Fiserv
FI
|
+$2.19B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| 1 | Technology | 34.76% |
| 2 | Financials | 12.08% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
976
Healthpeak Properties
DOC
$12.6B
| $17.7M | ﹤0.01% |
1,013,409
-1,185
| -0.1% | -$20.8K |
|
977
Essential Properties Realty Trust
EPRT
$5.94B
| $17.6M | ﹤0.01% |
550,503
-345,837
| -39% | -$11M |
|
978
UDR
UDR
$12.9B
| $17.5M | ﹤0.01% |
429,738
-2,548
| -0.6% | -$104K |
|
979
TriNet
TNET
$3.48B
| $17.4M | ﹤0.01% |
237,842
+910
| +0.4% | +$66.6K |
|
|
RAPP
980
Rapport Therapeutics
RAPP
$847M
| $17.3M | ﹤0.01% |
1,525,519
+452,311
| +42% | +$5.14M |
|
981
IES Holdings
IESC
$7.48B
| $17.3M | ﹤0.01% |
58,469
+991
| +2% | +$294K |
|
982
Entrada Therapeutics
TRDA
$203M
| $17.3M | ﹤0.01% |
2,567,478
-169,289
| -6% | -$1.14M |
|
983
Moderna
MRNA
$9.88B
| $17.2M | ﹤0.01% |
624,159
-18,789
| -3% | -$518K |
|
|
GLXY
984
Galaxy Digital Inc. Class A Common Stock
GLXY
$4.98B
| $17.2M | ﹤0.01% |
+785,141
| New | +$17.2M |
|
985
Nordson
NDSN
$12.8B
| $16.9M | ﹤0.01% |
78,958
+179
| +0.2% | +$38.4K |
|
986
Columbia Banking Systems
COLB
$7.87B
| $16.9M | ﹤0.01% |
722,409
+65,115
| +10% | +$1.52M |
|
987
C.H. Robinson
CHRW
$15.5B
| $16.8M | ﹤0.01% |
175,526
+3,498
| +2% | +$336K |
|
988
Aecom
ACM
$16.9B
| $16.8M | ﹤0.01% |
149,056
+12,097
| +9% | +$1.37M |
|
989
Arcos Dorados Holdings
ARCO
$1.49B
| $16.8M | ﹤0.01% |
2,129,756
-8,404,510
| -80% | -$66.3M |
|
990
SoFi Technologies
SOFI
$31.1B
| $16.7M | ﹤0.01% |
919,541
+49,778
| +6% | +$907K |
|
991
Coherent
COHR
$16.1B
| $16.6M | ﹤0.01% |
186,282
-176,494
| -49% | -$15.7M |
|
992
Roivant Sciences
ROIV
$9.84B
| $16.6M | ﹤0.01% |
1,471,223
+1,210,181
| +464% | +$13.6M |
|
993
ePlus
PLUS
$1.99B
| $16.6M | ﹤0.01% |
229,905
+2,732
| +1% | +$197K |
|
|
KMTS
994
Kestra Medical Technologies, Ltd. Common Stock
KMTS
$945M
| $16.5M | ﹤0.01% |
997,196
+147,778
| +17% | +$2.45M |
|
995
Euronet Worldwide
EEFT
$3.62B
| $16.5M | ﹤0.01% |
162,728
-323,698
| -67% | -$32.8M |
|
996
Skyworks Solutions
SWKS
$11.1B
| $16.5M | ﹤0.01% |
221,321
-9,410
| -4% | -$701K |
|
997
Bausch + Lomb
BLCO
$5.42B
| $16.3M | ﹤0.01% |
1,249,313
-32,587
| -3% | -$424K |
|
998
Catalyst Pharmaceutical
CPRX
$2.48B
| $16M | ﹤0.01% |
735,698
-241,925
| -25% | -$5.25M |
|
999
Paycom
PAYC
$12.7B
| $15.9M | ﹤0.01% |
68,593
-1,028
| -1% | -$238K |
|
1000
Bunge Global
BG
$16.4B
| $15.8M | ﹤0.01% |
196,604
-4,373
| -2% | -$351K |
|